Literature DB >> 10698183

Intraovarian excess of nerve growth factor increases androgen secretion and disrupts estrous cyclicity in the rat.

G A Dissen1, H E Lara, V Leyton, A Paredes, D F Hill, M E Costa, A Martinez-Serrano, S R Ojeda.   

Abstract

A single injection of estradiol valerate induces a form of cystic ovary resembling some aspects of the human polycystic ovarian syndrome. Preceding the development of follicular cysts, there is an increase in intraovarian synthesis of nerve growth factor (NGF) and the low affinity NGF receptor (p75 NGFR). Selective blockade of NGF actions and p75 NGFR synthesis in the ovary restored estrous cyclicity and ovulatory capacity in estradiol valerate-treated rats, suggesting that an increase in NGF-dependent, p75 NGFR-mediated actions within the ovary contributes to the development of cystic ovarian disease. We have tested this hypothesis by grafting NGF-producing neural progenitor cells into the ovary of juvenile rats that have been induced to ovulate precociously by a single injection of PMSG. The NGF-producing cells, detected by their content of immunoreactive p75 NGFR material, were found scattered throughout the ovary with some of them infiltrating the granulosa cell compartment of large, precystic follicles. Ovarian NGF content was 2-fold higher than in the ovary of rats receiving control cells. Estrous cyclicity was disrupted, with the animals showing prolonged periods of persistent estrus, and an almost continuous background of vaginal cornified cells at other phases of the estrous cycle. Morphometric analysis revealed that the presence of NGF-producing cells neither reduced the total number of corpora lutea per ovary nor significantly increased the formation of follicular cysts. However, the ovaries receiving these cells showed an increased incidence of precystic, type III follicles, accompanied by a reduced number of healthy antral follicles, and an increased size of both healthy and atretic follicles. These changes in follicular dynamics were accompanied by a selective increase in serum androstenedione levels. The results show that an abnormally elevated production of NGF within the ovary suffices to initiate several of the structural and functional alterations associated with the development of follicular cysts in the rat ovary.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10698183     DOI: 10.1210/endo.141.3.7396

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  18 in total

Review 1.  Role of stress and sympathetic innervation in the development of polycystic ovary syndrome.

Authors:  Monika Greiner; Alfonso Paredes; Verónica Araya; Hernán E Lara
Journal:  Endocrine       Date:  2005-12       Impact factor: 3.633

2.  Excessive ovarian production of nerve growth factor elicits granulosa cell apoptosis by setting in motion a tumor necrosis factor α/stathmin-mediated death signaling pathway.

Authors:  Cecilia Garcia-Rudaz; Mauricio Dorfman; Srinivasa Nagalla; Konstantin Svechnikov; Olle Söder; Sergio R Ojeda; Gregory A Dissen
Journal:  Reproduction       Date:  2011-06-06       Impact factor: 3.906

Review 3.  PCOS Forum: research in polycystic ovary syndrome today and tomorrow.

Authors:  Renato Pasquali; Elisabet Stener-Victorin; Bulent O Yildiz; Antoni J Duleba; Kathleen Hoeger; Helen Mason; Roy Homburg; Theresa Hickey; Steve Franks; Juha S Tapanainen; Adam Balen; David H Abbott; Evanthia Diamanti-Kandarakis; Richard S Legro
Journal:  Clin Endocrinol (Oxf)       Date:  2011-04       Impact factor: 3.478

4.  Unilateral sectioning of the superior ovarian nerve of rats with polycystic ovarian syndrome restores ovulation in the innervated ovary.

Authors:  Leticia Morales-Ledesma; Rosa Linares; Gabriela Rosas; Carolina Morán; Roberto Chavira; Mario Cárdenas; Roberto Domínguez
Journal:  Reprod Biol Endocrinol       Date:  2010-08-19       Impact factor: 5.211

5.  Excessive ovarian production of nerve growth factor facilitates development of cystic ovarian morphology in mice and is a feature of polycystic ovarian syndrome in humans.

Authors:  Gregory A Dissen; Cecilia Garcia-Rudaz; Alfonso Paredes; Christine Mayer; Artur Mayerhofer; Sergio R Ojeda
Journal:  Endocrinology       Date:  2009-03-05       Impact factor: 4.736

6.  Excess of nerve growth factor in the ovary causes a polycystic ovary-like syndrome in mice, which closely resembles both reproductive and metabolic aspects of the human syndrome.

Authors:  Jenny L Wilson; Weiyi Chen; Gregory A Dissen; Sergio R Ojeda; Michael A Cowley; Cecilia Garcia-Rudaz; Pablo J Enriori
Journal:  Endocrinology       Date:  2014-09-11       Impact factor: 4.736

7.  Genetic modeling of ovarian phenotypes in mice for the study of human polycystic ovary syndrome.

Authors:  Yi Feng; Xin Li; Ruijin Shao
Journal:  Am J Transl Res       Date:  2013-01-21       Impact factor: 4.060

8.  Enhanced at puberty 1 (EAP1) is a new transcriptional regulator of the female neuroendocrine reproductive axis.

Authors:  Sabine Heger; Claudio Mastronardi; Gregory A Dissen; Alejandro Lomniczi; Ricardo Cabrera; Christian L Roth; Heike Jung; Francesco Galimi; Wolfgang Sippell; Sergio R Ojeda
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

9.  Rats with steroid-induced polycystic ovaries develop hypertension and increased sympathetic nervous system activity.

Authors:  Elisabet Stener-Victorin; Karolina Ploj; Britt-Mari Larsson; Agneta Holmäng
Journal:  Reprod Biol Endocrinol       Date:  2005-09-07       Impact factor: 5.211

10.  Increases in norepinephrine release and ovarian cyst formation during ageing in the rat.

Authors:  Eric Acuña; Romina Fornes; Daniela Fernandois; Maritza P Garrido; Monika Greiner; Hernan E Lara; Alfonso H Paredes
Journal:  Reprod Biol Endocrinol       Date:  2009-06-16       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.